Are Variants in the CAPN10 Gene Related to Risk of Type 2 Diabetes? A Quantitative Assessment of Population and Family-Based Association Studies

American Journal of Human Genetics

Volumn 74, Issue 2, 2004, Pages 208-222

  Song, Yiqing ^a,b   Niu, Tianhua ^a   Manson, JoAnn E ^a,b   Kwiatkowski, David J ^c   Liu, Simin ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Hematology Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN;

ADULT; ARTICLE; CAPN10 GENE; CHROMOSOME 2Q; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MULTIGENE FAMILY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PRIORITY JOURNAL; QUANTITATIVE TRAIT; T2D GENE; UCSNP43 GENE;

EID: 0842285701     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/381400     Document Type: Article

References (51)

1. Altshuler D, Daly M, Kruglyak L (2000) Guilt by association. Nat Genet 26:135-137
2. Ardlie KG, Lunetta KL, Seielstad M (2002) Testing for population subdivision and association in four case-control studies. Am J Hum Genet 71:304-311
3. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen GQ, Mott D, Knowler WC, Cox NJ, Horikawa Y, Oda N, Bell GI, Bogardus C (2000) A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 106:R69-R73
4. Cardon LR, Bell JI (2001) Association study designs for complex diseases. Nat Rev Genet 2:91-99
5. Cassell PG, Jackson AE, North BV, Evans JC, Syndercombe-Court D, Phillips C, Ramachandran A, Snehalatha C, Gelding SV, Vijayaravaghan S, Curtis D, Hitman GA (2002) Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes 51:1622-1628
6. Cox NJ (2001) Challenges in identifying genetic variation affecting susceptibility to type 2 diabetes: examples from studies of the calpain-10 gene. Hum Mol Genet 10:2301-2305
7. - (2002) Calpain 10 and genetics of type 2 diabetes. Curr Diab Rep 2:186-190
8. Cox NJ, Frigge M, Nicolae DL, Concannon P, Hanis CL, Bell GI, Kong A (1999) Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet 21:213-215
9. Daimon M, Oizumi T, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H, Igarashi M, Manaka H, Kato T (2002) Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res Clin Pract 56:147-152
10. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES (2001) High-resolution haplotype structure in the human genome. Nat Genet 29:229-232
11. DerSimonian R, Laird NM (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
12. Egger M, Smith GD, Altman DG (2001) Systematic reviews in health care: meta-analysis in context. The BMJ Publishing Group, London
13. Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, Cox NJ, Hanis CL, Hasstedt SJ (2002) Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87:650-654
14. Engelman C, Barmada M, Ferrell R, Norris J (2003) Investigation of an interaction between Calpain-10 and CYP 19 in the susceptibility to type 2 diabetes. Diabetes 52 Suppl: A510-A511
15. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, Walker M, Levy JC, et al (2001) Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 69:544-552
16. Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, Mohlke KL, Silander K, Valle TT, Buchanan TA, Tuomilehto J, Bergman RN, Boehnke M, Collins FS (2002) Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes 51:1644-1648
17. Florez JC, Hirschhorn J, Altshuler D (2003) The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu Rev Genomics Hum Genet 4:257-291
18. Fullerton SM, Bartoszewicz A, Ybazeta G, Horikawa Y, Bell GI, Kidd KK, Cox NJ, Hudson RR, Di Rienzo A (2002) Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus. Am J Hum Genet 70:1096-1106
19. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229
20. Garant MJ, Kao WH, Brancati F, Coresh J, Rami TM, Hanis CL, Boerwinkle E, Shuldiner AR (2002) SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 51: 231-237
21. Gauderman WJ (2002) Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155: 478-484
22. Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83:731-801
23. Greenland S (1998) Applications of stratified analysis methods. In: Rothman KJ, Greenland S (eds) Modern epidemiology. Lippincott Williams & Wilkins, Philadelphia, pp 281-300
24. Hegele RA, Harris SB, Zinman B, Hanley AJ, Cao H (2001) Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree. Diabetes Care 24:1498-1499
25. 3-adrenoceptor function in human fat cells. J Clin Endocrinol Metab 87:3362-3367
26. Hoffstedt J, Ryden M, Lofgren P, Orho-Melander M, Groop L, Arner P (2002b) Polymorphism in the Calpain 10 gene influences glucose metabolism in human fat cells. Diabetologia 45:276-282
27. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163-175
28. Horikawa Y, Oda N, Yu L, Imamura S, Fujiwara K, Makino M, Seino Y, Itoh M, Takeda J (2003) Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese. J Clin Endocrinol Metab 88: 244-247
29. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29:306-309
30. Iwasaki N, Horikawa Y, Kitamura Y, Nakamura T, Tanizawa Y, Oka Y, Hara K, Kadowaki T, Honda M, Ogata M, Kamatani N, Cox NJ, Iwamoto Y (2003) Variations in the calpain 10 gene affect plasma glucose levels in non-diabetic subjects in Japanese. Diabetes 52 Suppl:A511-A512
31. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, Todd JA (2001) Haplotype tagging for the identification of common disease genes. Nat Genet 29:233-237
32. Kahn CR (1994) Banting Lecture: insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084
33. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988-1992
34. Lynn S, Evans JC, White C, Frayling TM, Hattersley AT, Turnbull DM, Horikawa Y, Cox NJ, Bell GI, Walker M (2002) Variation in the calpain-10 gene affects blood glucose levels in the British population. Diabetes 51:247-250
35. Malecki MT, Moczulski DK, Klupa T, Wanic K, Cyganek K, Frey J, Sieradzki J (2002) Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur J Endocrinol 146:695-699
36. Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD (1987) Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30: 763-768
37. Ng MCY, So W, Critchley JAJH, Cockram CS, Chan JCN (2001) Association of calpain 10 genetic polymorphisms with type 2 diabetes and insulin response in nondiabetic Chinese. Diabetes 50 Suppl 2:A234
38. Normand ST (1999) Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 18:321-359
39. Orho-Melander M, Klannemark M, Svensson MK, Ridderstrale M, Lindgren CM, Groop L (2002) Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 51:2658-2664
40. Pankow JS, Province MA, Hunt SC, Arnett DK (2002) Regarding "Testing for population subdivision and association in four case-control studies." Am J Hum Genet 71:1478-1480
41. Rasmussen SK, Urhammer SA, Berglund L, Jensen JN, Hansen L, Echwald SM, Borch-Johnsen K, Horikawa Y, Mashima H, Lithell H, Cox NJ, Hansen T, Bell GI, Pedersen O (2002) Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 51:3561-3567
42. Schwarz P, Fischer S, Goergens H, Koehler C, Graessler J, Fuecker K, Julius U, Schulze J, Schackert H, Hanefeld M (2003) Haplotype 112 in CAPN10 is associated with increased proinsulin values during 75 g OGTT in newly diagnosed type 2 diabetes. Diabetes 52 Suppl:A255
43. Schwarz PEH, Horikawa Y, Vcelak J, Selisko T, Rietzsch H, Bendlova B, Schulze J, Cox NJ (2001) Genetic variation of CAPN10 affects susceptibility to type 2 diabetes in German and Czech population. Diabetes 50 Suppl 2:A232
44. Shore AC, Evans JC, Frayling TM, Clark PM, Lee BC, Horikawa Y, Hattersley AT, Tooke JE (2002) Association of calpain-10 gene with microvascular function. Diabetologia 45:899-904
45. Stumvoll M, Fritsche A, Madaus A, Stefan N, Weisser M, Machicao F, Haring H (2001) Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. Diabetes 50:2161-2163
46. Stumvoll M, Wahl HG, Machicao F, Haring H (2002) Insulin sensitivity of glucose disposal and lipolysis: no influence of common genetic variants in IRS-1 and CAPN10. Diabetologia 45:651-656
47. Sun HX, Zhang KX, Du WN, Shi JX, Jiang ZW, Sun H, Zuo J, Huang W, Chen Z, Shen Y, Yao ZJ, Qiang BQ, Fang FD (2002) Single nucleotide polymorphisms in CAPN10 gene of Chinese people and its correlation with type 2 diabetes mellitus in Han people of northern China. Biomed Environ Sci 15:75-82
48. Tsai HJ, Sun G, Weeks DE, Kaushal R, Wolujewicz M, McGarvey ST, Tufa J, Viali S, Deka R (2001) Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. Am J Hum Genet 69:1236-1244
49. Wacholder S, Rothman N, Caporaso N (2000) Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 92:1151-1158
50. Xiang K, Fang Q, Zheng T, Jia W, Wang Y, Zhang R, Li J, Shen K (2001a) [The impact of calpain-10 gene combined-SNP variation on type 2 diabetes mellitus and its related metabolic traits]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18:426-430
51. Xiang K, Zheng T, Fang Q, Jia W, Wang Y, Zhang R, Sheng K, Lee J, Lu J, Lu H (2001b) Calpain-10 SNP43 polymorphism is associated with insulin sensitivity and insulin levels during glucose load in Chinese non-diabetic subjects. Diabetes 50 Suppl:A232